Fetalix has been awarded the ID Seal by Agência Nacional de Inovação (ANI), a distinction recognizing companies with strong activity in research, development, and technological innovation.
In Portugal, the ID Seal is an important recognition within the innovation ecosystem, identifying companies actively engaged in research and technological development. The distinction can also facilitate access to innovation support mechanisms and increase attractiveness to investors and strategic partners by reinforcing the company’s R&D credentials.
This milestone was supported through the contribution of the EIT Health InnoStars programme, Innoyse Partners, and Nuno Nazaré, whose guidance played an important role throughout the certification process.
The award further strengthens Fetalix’s positioning as a science-driven biotechnology company focused on developing innovative regenerative solutions for unmet medical needs.
February 19, 2025
